GCP
ABBV icon

Gill Capital Partners’s AbbVie ABBV Stock Holding History

Gill Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$400K Hold
1,590
– – 0.11% 99
2026
Q1 		$346K Sell
1,590
-23
-1% -$5.1K 0.1% 96
2025
Q4 		$369K Hold
1,613
– – 0.11% 90
2025
Q3 		$373K Sell
1,613
-730
-31% -$149K 0.11% 90
2025
Q2 		$435K Buy
2,343
+1
+0% +$186 0.14% 83
2025
Q1 		$491K Buy
2,342
+601
+35% +$117K 0.17% 75
2024
Q4 		$309K Buy
1,741
+701
+67% +$129K 0.11% 91
2024
Q3 		$205K Buy
+1,040
New +$194K 0.07% 122

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gill Capital Partners's ABBV Position: Q2 2026 in Review

Gill Capital Partners held its AbbVie (ABBV) position steady in Q2 2026 at 1,590 shares worth $400K. The position accounts for 0.11% of the portfolio, ranked #99.

Gill Capital Partners first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. The position peaked at $491K in Q1 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Gill Capital Partners held 1,590 shares of AbbVie worth $400K as of Q2 2026.
  • Gill Capital Partners left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.11% of Gill Capital Partners's portfolio in Q2 2026, its #99 holding.
  • Gill Capital Partners first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • Gill Capital Partners's AbbVie position peaked at $491K in Q1 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.